National Israel Ovarian Cancer Study Group[Corporate Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2001	1
2005	1
2022	1
2025	0

Page 1

Subfertility, use of fertility treatments and BRCA mutation status and the risk of ovarian cancer.

Lerner-Geva L, Chetrit A, Farhi A, Lubin F, Sadezki S; National Israel Ovarian Cancer Study Group. Lerner-Geva L, et al. Arch Gynecol Obstet. 2022 Jul;306(1):209-217. doi: 10.1007/s00404-021-06355-6. Epub 2022 Jan 18. Arch Gynecol Obstet. 2022. PMID: 35039881

Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.

Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, Modan B, Ben-Baruch G; National Israel Ovarian Cancer Study Group. Gotlieb WH, et al. Gynecol Oncol. 2005 Jun;97(3):780-3. doi: 10.1016/j.ygyno.2005.02.022. Gynecol Oncol. 2005. PMID: 15893369

Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.

Modan B, Hartge P, Hirsh-Yechezkel G, Chetrit A, Lubin F, Beller U, Ben-Baruch G, Fishman A, Menczer J, Struewing JP, Tucker MA, Wacholder S; National Israel Ovarian Cancer Study Group. Modan B, et al. N Engl J Med. 2001 Jul 26;345(4):235-40. doi: 10.1056/NEJM200107263450401. N Engl J Med. 2001. PMID: 11474660 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year